Published in Proc Natl Acad Sci U S A on June 14, 2012
Endotoxemia-mediated inflammation potentiates aminoglycoside-induced ototoxicity. Sci Transl Med (2015) 1.57
Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention. Anat Rec (Hoboken) (2012) 1.38
4'-O-substitutions determine selectivity of aminoglycoside antibiotics. Nat Commun (2014) 1.12
Strategies to overcome the action of aminoglycoside-modifying enzymes for treating resistant bacterial infections. Future Med Chem (2013) 1.10
The evolving role of chemical synthesis in antibacterial drug discovery. Angew Chem Int Ed Engl (2014) 1.05
Designer aminoglycosides that selectively inhibit cytoplasmic rather than mitochondrial ribosomes show decreased ototoxicity: a strategy for the treatment of genetic diseases. J Biol Chem (2013) 1.01
A novel role of cytosolic protein synthesis inhibition in aminoglycoside ototoxicity. J Neurosci (2013) 1.01
The mitochondrion: a perpetrator of acquired hearing loss. Hear Res (2013) 0.99
New trends in aminoglycosides use. Medchemcomm (2014) 0.96
The impact of aminoglycosides on the dynamics of translation elongation. Cell Rep (2013) 0.92
Prospects for circumventing aminoglycoside kinase mediated antibiotic resistance. Front Cell Infect Microbiol (2013) 0.85
Identification of the molecular attributes required for aminoglycoside activity against Leishmania. Proc Natl Acad Sci U S A (2013) 0.85
Mitochondrial peroxiredoxin 3 regulates sensory cell survival in the cochlea. PLoS One (2013) 0.84
Assessment of nutrient supplement to reduce gentamicin-induced ototoxicity. J Assoc Res Otolaryngol (2014) 0.83
Mitochondrial m.1584A 12S m62A rRNA methylation in families with m.1555A>G associated hearing loss. Hum Mol Genet (2014) 0.83
When Proteins Start to Make Sense: Fine-tuning Aminoglycosides for PTC Suppression Therapy. Medchemcomm (2014) 0.83
Structural basis for selective targeting of leishmanial ribosomes: aminoglycoside derivatives as promising therapeutics. Nucleic Acids Res (2015) 0.81
Validation of a High-Throughput Screening Assay for Identification of Adjunctive and Directly Acting Antimicrobials Targeting Carbapenem-Resistant Enterobacteriaceae. Assay Drug Dev Technol (2016) 0.81
In vitro and in vivo Evaluation of Synergism between Anti-Tubercular Spectinamides and Non-Classical Tuberculosis Antibiotics. Sci Rep (2015) 0.81
Metformin protects against gentamicin-induced hair cell death in vitro but not ototoxicity in vivo. Neurosci Lett (2014) 0.80
Identification and evaluation of improved 4'-O-(alkyl) 4,5-disubstituted 2-deoxystreptamines as next-generation aminoglycoside antibiotics. MBio (2014) 0.80
XBP1 mitigates aminoglycoside-induced endoplasmic reticulum stress and neuronal cell death. Cell Death Dis (2015) 0.79
In vivo efficacy of apramycin in murine infection models. Antimicrob Agents Chemother (2014) 0.79
Designer aminoglycosides prevent cochlear hair cell loss and hearing loss. J Clin Invest (2015) 0.78
Characterization of new-generation aminoglycoside promoting premature termination codon readthrough in cancer cells. RNA Biol (2017) 0.76
Protecting Mammalian Hair Cells from Aminoglycoside-Toxicity: Assessing Phenoxybenzamine's Potential. Front Cell Neurosci (2017) 0.75
Frequency and Demographics of Gentamicin Use. Otol Neurotol (2016) 0.75
Alternative synthesis and antibacterial evaluation of 1,5-dideoxy-1,5-imino-l-rhamnitol. Carbohydr Res (2015) 0.75
Detection and Quantification of Ribosome Inhibition by Aminoglycoside Antibiotics in Living Bacteria Using an Orthogonal Ribosome-Controlled Fluorescent Reporter. ACS Chem Biol (2015) 0.75
d-Methionine reduces tobramycin-induced ototoxicity without antimicrobial interference in animal models. J Cyst Fibros (2015) 0.75
Indium-mediated allylation in carbohydrate synthesis: A short and efficient approach towards higher 2-acetamido-2-deoxy sugars. Beilstein J Org Chem (2014) 0.75
Gentamicin differentially alters cellular metabolism of cochlear hair cells as revealed by NAD(P)H fluorescence lifetime imaging. J Biomed Opt (2015) 0.75
Resistance mutations generate divergent antibiotic susceptibility profiles against translation inhibitors. Proc Natl Acad Sci U S A (2016) 0.75
Structure-Based Design and Synthesis of Apramycin-Paromomycin Analogues. Importance of the Configuration at the 6'-Position and Differences Between the 6'-Amino and Hydroxy Series. J Am Chem Soc (2017) 0.75
Parallel pathways in the biosynthesis of aminoglycoside antibiotics. F1000Res (2017) 0.75
Structure of the 30S ribosomal subunit. Nature (2000) 23.11
Functional insights from the structure of the 30S ribosomal subunit and its interactions with antibiotics. Nature (2000) 11.30
Interaction of antibiotics with functional sites in 16S ribosomal RNA. Nature (1987) 8.96
Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nat Genet (1993) 4.49
Misreading of RNA codewords induced by aminoglycoside antibiotics. Mol Pharmacol (1965) 4.45
Programmes and principles in treatment of multidrug-resistant tuberculosis. Lancet (2004) 4.21
A dual-luciferase reporter system for studying recoding signals. RNA (1998) 3.92
Aminoglycoside antibiotics. Audiol Neurootol (2000) 2.77
Crystal structure of paromomycin docked into the eubacterial ribosomal decoding A site. Structure (2001) 2.57
Crystal structures of complexes between aminoglycosides and decoding A site oligonucleotides: role of the number of rings and positive charges in the specific binding leading to miscoding. Nucleic Acids Res (2005) 2.51
Mitochondrial dysfunction and molecular pathways of disease. Exp Mol Pathol (2007) 2.50
Conformational changes of the small ribosomal subunit during elongation factor G-dependent tRNA-mRNA translocation. J Mol Biol (2004) 2.41
Conformational switch in the decoding region of 16S rRNA during aminoacyl-tRNA selection on the ribosome. Nat Struct Biol (2000) 2.05
N-methyl-D-aspartate antagonists limit aminoglycoside antibiotic-induced hearing loss. Nat Med (1996) 1.69
Discrimination between defects in elongation fidelity and termination efficiency provides mechanistic insights into translational readthrough. J Mol Biol (2005) 1.65
Structural basis for selectivity and toxicity of ribosomal antibiotics. EMBO Rep (2001) 1.61
Structure-activity relationships among the aminoglycoside antibiotics: role of hydroxyl and amino groups. Antimicrob Agents Chemother (1973) 1.46
Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates. J Antimicrob Chemother (2010) 1.43
New developments in aminoglycoside therapy and ototoxicity. Hear Res (2011) 1.35
Engineering the rRNA decoding site of eukaryotic cytosolic ribosomes in bacteria. Nucleic Acids Res (2007) 1.30
Mitochondrial deafness alleles confer misreading of the genetic code. Proc Natl Acad Sci U S A (2008) 1.29
Genetic analysis of interactions with eukaryotic rRNA identify the mitoribosome as target in aminoglycoside ototoxicity. Proc Natl Acad Sci U S A (2008) 1.27
A comprehensive analysis of translational missense errors in the yeast Saccharomyces cerevisiae. RNA (2010) 1.27
Eukaryotic ribosomal RNA determinants of aminoglycoside resistance and their role in translational fidelity. RNA (2007) 1.26
Aminoglycoside activity observed on single pre-translocation ribosome complexes. Nat Chem Biol (2009) 1.23
Aminoglycoside antibiotics. Structures, functions, and resistance. Adv Exp Med Biol (1998) 1.23
Inhibition of ribosomal translocation by aminoglycoside antibiotics. Biochem Biophys Res Commun (1978) 1.22
Differential damage to auditory neurons and hair cells by ototoxins and neuroprotection by specific neurotrophins in rat cochlear organotypic cultures. Eur J Neurosci (1996) 1.17
Analysis of the contribution of individual substituents in 4,6-aminoglycoside-ribosome interaction. Antimicrob Agents Chemother (2005) 1.15
Apramycin, a unique aminocyclitol antibiotic. J Org Chem (1976) 1.14
Molecular recognition by glycoside pseudo base pairs and triples in an apramycin-RNA complex. Angew Chem Int Ed Engl (2005) 1.08
Effects of apramycin, a novel aminoglycoside antibiotic on bacterial protein synthesis. Eur J Biochem (1979) 1.08
Aminoglycoside-induced histone deacetylation and hair cell death in the mouse cochlea. J Neurochem (2009) 1.07
Stimulation of free radical formation by aminoglycoside antibiotics. Hear Res (1999) 1.06
Pivotal role of Harakiri in the induction and prevention of gentamicin-induced hearing loss. Proc Natl Acad Sci U S A (2005) 1.02
Rac/Rho pathway regulates actin depolymerization induced by aminoglycoside antibiotics. J Neurosci Res (2006) 0.97
Mitochondrial DNA mutation-elicited oxidative stress, oxidative damage, and altered gene expression in cultured cells of patients with MERRF syndrome. Mol Neurobiol (2010) 0.92
The in vitro activity of apramycin, a new aminocyclitol antibiotic. J Antimicrob Chemother (1977) 0.90
Antimicrobial agents targeting the ribosome: the issue of selectivity and toxicity - lessons to be learned. Cell Mol Life Sci (2007) 0.86
Aminoglycosides inhibit KCNQ4 channels in cochlear outer hair cells via depletion of phosphatidylinositol(4,5)bisphosphate. Mol Pharmacol (2010) 0.85
Are aminoglycoside antibiotics excitotoxic? Neuroreport (1998) 0.83
The antibacterial and NMDA receptor activating properties of aminoglycosides are dissociable. Eur J Pharmacol (2000) 0.81
Structure of the 30S ribosomal subunit. Nature (2000) 23.11
Structure of the 70S ribosome complexed with mRNA and tRNA. Science (2006) 12.25
Functional insights from the structure of the 30S ribosomal subunit and its interactions with antibiotics. Nature (2000) 11.30
Recognition of cognate transfer RNA by the 30S ribosomal subunit. Science (2001) 8.68
Selection of tRNA by the ribosome requires a transition from an open to a closed form. Cell (2002) 5.62
Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature (2001) 5.51
Structural insights into translational fidelity. Annu Rev Biochem (2005) 4.97
The structural basis for the action of the antibiotics tetracycline, pactamycin, and hygromycin B on the 30S ribosomal subunit. Cell (2000) 4.82
The structure of the ribosome with elongation factor G trapped in the posttranslocational state. Science (2009) 4.26
What recent ribosome structures have revealed about the mechanism of translation. Nature (2009) 4.01
Sexual orientation and suicidality: a co-twin control study in adult men. Arch Gen Psychiatry (1999) 3.97
Crystal structure of the 30 S ribosomal subunit from Thermus thermophilus: structure of the proteins and their interactions with 16 S RNA. J Mol Biol (2002) 3.76
A detailed view of a ribosomal active site: the structure of the L11-RNA complex. Cell (1999) 3.70
Crystal structure of an initiation factor bound to the 30S ribosomal subunit. Science (2001) 3.51
Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results. J Clin Oncol (2002) 3.49
The eukaryotic translation initiation factors eIF1 and eIF1A induce an open conformation of the 40S ribosome. Mol Cell (2007) 3.44
Insights into substrate stabilization from snapshots of the peptidyl transferase center of the intact 70S ribosome. Nat Struct Mol Biol (2009) 3.25
Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled. J Neurosci (2006) 3.20
Structure of a bacterial 30S ribosomal subunit at 5.5 A resolution. Nature (1999) 3.12
Retinal vascular caliber and the development of hypertension: a meta-analysis of individual participant data. J Hypertens (2014) 2.83
Insights into the decoding mechanism from recent ribosome structures. Trends Biochem Sci (2003) 2.71
GTPase activation of elongation factor EF-Tu by the ribosome during decoding. EMBO J (2009) 2.71
Visualizing tmRNA entry into a stalled ribosome. Science (2003) 2.67
Crystal structures of the ribosome in complex with release factors RF1 and RF2 bound to a cognate stop codon. Cell (2005) 2.46
A complete mapping of the proteins in the small ribosomal subunit of Escherichia coli. Science (1987) 2.43
Prevalence of asthma and other allergic diseases in an adolescent population: association with gender and race. Ann Allergy Asthma Immunol (2001) 2.19
Elongation factor G bound to the ribosome in an intermediate state of translocation. Science (2013) 2.12
Ligand-induced folding of the adenosine deaminase A-riboswitch and implications on riboswitch translational control. Chembiochem (2007) 2.12
Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation. Brain (2010) 2.11
How mutations in tRNA distant from the anticodon affect the fidelity of decoding. Nat Struct Mol Biol (2011) 2.10
Fitness cost of chromosomal drug resistance-conferring mutations. Antimicrob Agents Chemother (2002) 2.07
The proteinase-activated receptor 2 is induced by inflammatory mediators in human endothelial cells. Comparison with the thrombin receptor. J Biol Chem (1996) 2.05
Calcite precipitation induced by polyurethane-immobilized Bacillus pasteurii. Enzyme Microb Technol (2001) 2.04
Relationships of race and socioeconomic status with prevalence, severity, and symptoms of asthma in Chicago school children. Ann Allergy Asthma Immunol (1998) 2.01
The structural basis for mRNA recognition and cleavage by the ribosome-dependent endonuclease RelE. Cell (2009) 2.01
Quantitative drug susceptibility testing of Mycobacterium tuberculosis by use of MGIT 960 and EpiCenter instrumentation. J Clin Microbiol (2009) 1.98
Structure of the histone acetyltransferase Hat1: a paradigm for the GCN5-related N-acetyltransferase superfamily. Cell (1998) 1.96
Reduced thymic output is a major mechanism of immune reconstitution failure in HIV-infected patients after long-term antiretroviral therapy. Clin Infect Dis (2011) 1.82
NF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcome. Cell (2010) 1.81
Chromatin higher-order structure studied by neutron scattering and scanning transmission electron microscopy. Proc Natl Acad Sci U S A (1987) 1.77
Linker histone-dependent DNA structure in linear mononucleosomes. J Mol Biol (1996) 1.76
Quantifying the predictability of diaphragm motion during respiration with a noninvasive external marker. Med Phys (2003) 1.76
Structural and biochemical evidence for a boat-like transition state in beta-mannosidases. Nat Chem Biol (2008) 1.75
Crystal structure of the 30 S ribosomal subunit from Thermus thermophilus: purification, crystallization and structure determination. J Mol Biol (2001) 1.74
White matter plasticity in the corticospinal tract of musicians: a diffusion tensor imaging study. Neuroimage (2009) 1.74
Endothelial-vasoprotective effects of high-density lipoprotein are impaired in patients with type 2 diabetes mellitus but are improved after extended-release niacin therapy. Circulation (2009) 1.73
Framingham Stroke Risk Profile and poor cognitive function: a population-based study. BMC Neurol (2008) 1.71
Glaucoma prevalence in Indigenous Australians. Br J Ophthalmol (2010) 1.70
Crystal structure of the histone acetyltransferase Hpa2: A tetrameric member of the Gcn5-related N-acetyltransferase superfamily. J Mol Biol (1999) 1.70
A universal method to produce in vitro transcripts with homogeneous 3' ends. Nucleic Acids Res (2002) 1.67
Structure of a purine-purine wobble base pair in the decoding center of the ribosome. Nat Struct Mol Biol (2004) 1.66
Structural basis of the translational elongation cycle. Annu Rev Biochem (2013) 1.65
gyrA mutations and phenotypic susceptibility levels to ofloxacin and moxifloxacin in clinical isolates of Mycobacterium tuberculosis. J Antimicrob Chemother (2012) 1.65
Oxidative imbalance in the aging inner ear. Neurobiol Aging (2006) 1.64
Traumatic noise activates Rho-family GTPases through transient cellular energy depletion. J Neurosci (2012) 1.63
The rationale for using rifabutin in the treatment of MDR and XDR tuberculosis outbreaks. PLoS One (2013) 1.62
Position and orientation of the globular domain of linker histone H5 on the nucleosome. Nature (1998) 1.62
The molecular basis for A-site mutations conferring aminoglycoside resistance: relationship between ribosomal susceptibility and X-ray crystal structures. Chembiochem (2003) 1.60
Mechanism for expanding the decoding capacity of transfer RNAs by modification of uridines. Nat Struct Mol Biol (2007) 1.58
Identification of two DNA-binding sites on the globular domain of histone H5. EMBO J (1996) 1.57
Increasing prevalence and low awareness, treatment and control of diabetes mellitus among Chinese adults: the InterASIA study. Diabetes Res Clin Pract (2008) 1.57
Solvatochromic study of 1,2-dihydroxyanthraquinone in neat and binary solvent mixtures. Spectrochim Acta A Mol Biomol Spectrosc (2007) 1.55
The functional anatomy of inspection time: an event-related fMRI study. Neuroimage (2004) 1.53
Development of novel aminoglycoside (NB54) with reduced toxicity and enhanced suppression of disease-causing premature stop mutations. J Med Chem (2009) 1.53
Dobutamine-mediated heme oxygenase-1 induction via PI3K and p38 MAPK inhibits high mobility group box 1 protein release and attenuates rat myocardial ischemia/reperfusion injury in vivo. J Surg Res (2013) 1.52
Crystal structure of prokaryotic ribosomal protein L9: a bi-lobed RNA-binding protein. EMBO J (1994) 1.52
Activation of apoptotic pathways in the absence of cell death in an inner-ear immortomouse cell line. Hear Res (2011) 1.51
Location of translational initiation factor IF3 on the small ribosomal subunit. Proc Natl Acad Sci U S A (1999) 1.51
A network for audio-motor coordination in skilled pianists and non-musicians. Brain Res (2007) 1.50
Structural evidence for specific S8-RNA and S8-protein interactions within the 30S ribosomal subunit: ribosomal protein S8 from Bacillus stearothermophilus at 1.9 A resolution. Structure (1996) 1.49
Delayed production of free radicals following noise exposure. Brain Res (2004) 1.47
Suppression of RNA silencing by a geminivirus nuclear protein, AC2, correlates with transactivation of host genes. J Virol (2005) 1.46
Crystal structure of the ribosome recycling factor bound to the ribosome. Nat Struct Mol Biol (2007) 1.45
Genetic organization and functional analysis of the type III secretion system of Bradyrhizobium elkanii. FEMS Microbiol Lett (2009) 1.44
Massive-star supernovae as major dust factories. Science (2006) 1.43
Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease. Mov Disord (2003) 1.43
On the lateralization of emotional prosody: an event-related functional MR investigation. Brain Lang (2003) 1.42
Endoscopically-assisted excision of scapular osteochondroma. Acta Orthop Scand (1999) 1.42
Expanding the genetic code of Drosophila melanogaster. Nat Chem Biol (2012) 1.41
Glaucomatous optic neuropathy evaluation project: a standardized internet system for assessing skills in optic disc examination. Clin Experiment Ophthalmol (2011) 1.39
Crystal structure of the hybrid state of ribosome in complex with the guanosine triphosphatase release factor 3. Proc Natl Acad Sci U S A (2011) 1.37
Near-vision impairment and unresolved vision problems in Indigenous Australian adults. Clin Experiment Ophthalmol (2012) 1.37
X-ray crystallography shows that translational initiation factor IF3 consists of two compact alpha/beta domains linked by an alpha-helix. EMBO J (1995) 1.37
Enhanced visibility of hydrogen atoms by neutron crystallography on fully deuterated myoglobin. Proc Natl Acad Sci U S A (2000) 1.36
Fabrication of ultralong and electrically uniform single-walled carbon nanotubes on clean substrates. Nano Lett (2009) 1.35
New developments in aminoglycoside therapy and ototoxicity. Hear Res (2011) 1.35
Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours. Brain (2012) 1.34
Age-related auditory pathology in the CBA/J mouse. Hear Res (2008) 1.34
Reconstitution of chromatin higher-order structure from histone H5 and depleted chromatin. J Mol Biol (1988) 1.34
The functions of OmpATb, a pore-forming protein of Mycobacterium tuberculosis. Mol Microbiol (2002) 1.32
Paradoxes in advance care planning: the complex relationship of oncology patients, their physicians, and advance medical directives. J Clin Oncol (2009) 1.30
Modified uridines with C5-methylene substituents at the first position of the tRNA anticodon stabilize U.G wobble pairing during decoding. J Biol Chem (2008) 1.30
Precision top-quark mass measurement at CDF. Phys Rev Lett (2012) 1.30
The application of the sinusoidal model to lung cancer patient respiratory motion. Med Phys (2005) 1.30
Engineering the rRNA decoding site of eukaryotic cytosolic ribosomes in bacteria. Nucleic Acids Res (2007) 1.30
Traceless and site-specific ubiquitination of recombinant proteins. J Am Chem Soc (2011) 1.29